Search research articles
Contact Us
Filters
Showing results (211-220 of 282) with videos related to
Page
of 29
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 1, 1993
The use of recombinant human granulocyte-macrophage colony-stimulating factor with combination chemotherapy in the treatment of advanced adult soft-tissue sarcomas: early results from the EORTC Soft-Tissue and Bone Sarcoma Group
W P Steward, J Verweij, R Somers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1993
Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
W P Steward, J Verweij, R Somers, et al.
Behring Institute Mitteilungen
|
August 1, 1988
Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer
M Bronchud, J H Scarffe, N Thatcher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 1991
Interferon-alpha 2b in the treatment of follicular lymphoma: preliminary results of a trial in progress
C G Price, A Z Rohatiner, W Steward, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 1994
Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma
A Rohatiner, F d'Amore, B Coiffier, et al.
Blood
|
September 15, 1992
Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial
R Pettengell, H Gurney, J A Radford, et al.
British Journal of Cancer
|
April 1, 1977
Early central nervous system involvement in adults with acute non-myelogenous leukaemia
T A Lister, J M Whitehouse, M E Beard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 1993
A randomised dose intensity study in ovarian carcinoma comparing chemotherapy given at four week intervals for six cycles with half dose chemotherapy given for twelve cycles
D Murphy, D Crowther, J Renninson, et al.
British Medical Journal
|
March 18, 1978
MVPP chemotherapy regimen for advanced Hodgkin's disease
S B Sutcliffe, P F Wrigley, J Peto, et al.
British Journal of Cancer
|
August 1, 1995
A phase I trial of bryostatin 1 in patients with advanced malignancy using a 24 hour intravenous infusion
G C Jayson, D Crowther, J Prendiville, et al.
Page
of 29
Search research articles
Search
Showing results (211-220 of 282) with videos related to
Sort By:
Page
of 29
Cancer Chemotherapy and Pharmacology
|
January 1, 1993
The use of recombinant human granulocyte-macrophage colony-stimulating factor with combination chemotherapy in the treatment of advanced adult soft-tissue sarcomas: early results from the EORTC Soft-Tissue and Bone Sarcoma Group
W P Steward, J Verweij, R Somers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1993
Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
W P Steward, J Verweij, R Somers, et al.
Behring Institute Mitteilungen
|
August 1, 1988
Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer
M Bronchud, J H Scarffe, N Thatcher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 1991
Interferon-alpha 2b in the treatment of follicular lymphoma: preliminary results of a trial in progress
C G Price, A Z Rohatiner, W Steward, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 1994
Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma
A Rohatiner, F d'Amore, B Coiffier, et al.
Blood
|
September 15, 1992
Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial
R Pettengell, H Gurney, J A Radford, et al.
British Journal of Cancer
|
April 1, 1977
Early central nervous system involvement in adults with acute non-myelogenous leukaemia
T A Lister, J M Whitehouse, M E Beard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 1993
A randomised dose intensity study in ovarian carcinoma comparing chemotherapy given at four week intervals for six cycles with half dose chemotherapy given for twelve cycles
D Murphy, D Crowther, J Renninson, et al.
British Medical Journal
|
March 18, 1978
MVPP chemotherapy regimen for advanced Hodgkin's disease
S B Sutcliffe, P F Wrigley, J Peto, et al.
British Journal of Cancer
|
August 1, 1995
A phase I trial of bryostatin 1 in patients with advanced malignancy using a 24 hour intravenous infusion
G C Jayson, D Crowther, J Prendiville, et al.
Page
of 29